Recursion Pharmaceuticals Inc (RXRX) Price
RXRX Stock Price Chart
RXRX Financial
Recursion Pharmaceuticals Inc
$4.71
4.66%
$0.21
Income
Balance sheet
Cash flow
Annual
Quarterly
RXRX Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 64 | 58 | 44 | 39 | 10 | 3 |
| Revenue Growth (YoY) | 31% | 32% | 13% | 290% | 233% | 50% |
| Cost of Revenue | 66 | 45 | 42 | 48 | -- | -- |
| Gross Profit | -2 | 13 | 1 | -8 | -- | -- |
| Selling, General & Admin | 216 | 178 | 133 | 95 | 66 | 27 |
| Research & Development | 419 | 295 | 208 | 141 | 125 | 61 |
| Operating Expenses | 647 | 492 | 350 | 237 | 192 | 88 |
| Other Non Operating Income (Expenses) | -7 | 0 | -1 | 0 | 0 | 0 |
| Pretax Income | -649 | -464 | -332 | -239 | -186 | -87 |
| Income Tax Expense | 0 | -1 | -4 | -- | -- | -- |
| Net Income | -649 | -463 | -328 | -239 | -186 | -87 |
| Net Income Growth | 74% | 41% | 37% | 28% | 113.99% | 43% |
| Shares Outstanding (Diluted) | 417.36 | 274.2 | 207.85 | 175.54 | 125.35 | 162.16 |
| Shares Change (YoY) | 72% | 32% | 18% | 40% | -23% | 0% |
| EPS (Diluted) | -1.55 | -1.69 | -1.57 | -1.36 | -1.49 | -0.54 |
| EPS Growth | 1% | 7% | 16% | -9% | 176% | 42% |
| Free Cash Flow | -393 | -372 | -299 | -120 | -198 | -51 |
| Free Cash Flow Per Share | -0.94 | -1.35 | -1.43 | -0.68 | -1.57 | -0.31 |
| Gross Margin | -3.12% | 22.41% | 2.27% | -20.51% | -- | -- |
| Operating Margin | -1,014.06% | -825.86% | -790.9% | -628.2% | -1,820% | -2,800% |
| Profit Margin | -1,014.06% | -798.27% | -745.45% | -612.82% | -1,860% | -2,900% |
| Free Cash Flow Margin | -614.06% | -641.37% | -679.54% | -307.69% | -1,980% | -1,700% |
| EBITDA | -586 | -443 | -324 | -234 | -174 | -80 |
| EBITDA Margin | -915.62% | -763.79% | -736.36% | -600% | -1,739.99% | -2,666.66% |
| D&A For EBITDA | 63 | 36 | 24 | 11 | 8 | 4 |
| EBIT | -649 | -479 | -348 | -245 | -182 | -84 |
| EBIT Margin | -1,014.06% | -825.86% | -790.9% | -628.2% | -1,820% | -2,800% |
| Effective Tax Rate | 0% | 0.21% | 1.2% | -- | -- | -- |
Follow-Up Questions
Recursion Pharmaceuticals Incの主要な財務諸表は何ですか？
RXRXの主要な財務比率は何ですか？
Recursion Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？
Recursion Pharmaceuticals Incは収益を上げていますか？
Recursion Pharmaceuticals Incに負債はありますか？
Recursion Pharmaceuticals Incの発行済株式数は何株ですか？
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About RXRX